Recovery of infectious human immunodeficiency virus from cells treated with 1% paraformaldehyde

C H Aloisio1, J K Nicholson

  • 1Centers for Disease Control, Department of Health and Human Services, Atlanta, GA 30333.

Insights

Fixing cells with 1% paraformaldehyde significantly reduces human immunodeficiency virus (HIV) infectivity. However, this common lab method does not fully inactivate HIV in treated cells, even after 18 hours.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • 1% paraformaldehyde fixation is standard for flow cytometry of HIV-infected cells.
  • Previous research suggests 1% paraformaldehyde inactivates cell-free HIV.

Purpose of the Study:

  • To evaluate the efficacy of 1% paraformaldehyde in inactivating cell-associated HIV.
  • To assess inactivation in both chronically infected cell lines and acutely infected primary lymphocytes.

Main Methods:

  • Testing 1% paraformaldehyde inactivation on an HIV-infected cell line.
  • Assessing inactivation on peripheral blood lymphocytes acutely infected with HIV.
  • Measuring infectious titer reduction post-treatment.

Main Results:

  • A significant reduction in infectious titer was observed after 1% paraformaldehyde treatment.
  • Complete inactivation of HIV was not achieved, even with treatment up to 18 hours.

Conclusions:

  • 1% paraformaldehyde significantly reduces, but does not eliminate, HIV infectivity in cells.
  • Caution is advised when handling paraformaldehyde-fixed HIV-infected cells, as they may remain infectious.

Related Concept Videos